GSK (GSK)
GSK Statistics
Share Statistics
GSK has 2.03B shares outstanding. The number of shares has increased by 0.55% in one year.
| Shares Outstanding | 2.03B |
| Shares Change (YoY) | 0.55% |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | 8.36% |
| Shares Floating | 3.96B |
| Failed to Deliver (FTD) Shares | 266 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 17.89M, so 0.88% of the outstanding shares have been sold short.
| Short Interest | 17.89M |
| Short % of Shares Out | 0.88% |
| Short % of Float | 0.88% |
| Short Ratio (days to cover) | 4.87 |
Valuation Ratios
The PE ratio is 21.32 and the forward PE ratio is 8.66. GSK's PEG ratio is -0.44.
| PE Ratio | 21.32 |
| Forward PE | 8.66 |
| PS Ratio | 1.75 |
| Forward PS | 1.7 |
| PB Ratio | 4.02 |
| P/FCF Ratio | 15.37 |
| PEG Ratio | -0.44 |
Enterprise Valuation
GSK has an Enterprise Value (EV) of 133.16B.
| EV / Earnings | 51.71 |
| EV / Sales | 4.24 |
| EV / EBITDA | 19.97 |
| EV / EBIT | 33.12 |
| EV / FCF | 37.28 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.24.
| Current Ratio | 0.78 |
| Quick Ratio | 0.52 |
| Debt / Equity | 1.24 |
| Total Debt / Capitalization | 55.41 |
| Cash Flow / Debt | 0.39 |
| Interest Coverage | 6.28 |
Financial Efficiency
Return on equity (ROE) is 0.19% and return on capital (ROIC) is 11.35%.
| Return on Equity (ROE) | 0.19% |
| Return on Assets (ROA) | 0.04% |
| Return on Capital (ROIC) | 11.35% |
| Revenue Per Employee | $457,182.82 |
| Profits Per Employee | $37,520.58 |
| Employee Count | 68,629 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.6 |
Taxes
| Income Tax | 526M |
| Effective Tax Rate | 0.15 |
Stock Price Statistics
The stock price has increased by -10.15% in the last 52 weeks. The beta is 0.29, so GSK's price volatility has been higher than the market average.
| Beta | 0.29 |
| 52-Week Price Change | -10.15% |
| 50-Day Moving Average | 37.04 |
| 200-Day Moving Average | 38.03 |
| Relative Strength Index (RSI) | 50.87 |
| Average Volume (20 Days) | 4.92M |
Income Statement
In the last 12 months, GSK had revenue of 31.38B and earned 2.58B in profits. Earnings per share was 0.63.
| Revenue | 31.38B |
| Gross Profit | 22.33B |
| Operating Income | 4.02B |
| Net Income | 2.58B |
| EBITDA | 6.67B |
| EBIT | 4.02B |
| Earnings Per Share (EPS) | 0.63 |
Balance Sheet
The company has 3.69B in cash and 16.99B in debt, giving a net cash position of -13.29B.
| Cash & Cash Equivalents | 3.69B |
| Total Debt | 16.99B |
| Net Cash | -13.29B |
| Retained Earnings | 7.8B |
| Total Assets | 59.46B |
| Working Capital | -4.7B |
Cash Flow
In the last 12 months, operating cash flow was 6.55B and capital expenditures -2.98B, giving a free cash flow of 3.57B.
| Operating Cash Flow | 6.55B |
| Capital Expenditures | -2.98B |
| Free Cash Flow | 3.57B |
| FCF Per Share | 0.88 |
Margins
Gross margin is 71.16%, with operating and profit margins of 12.82% and 8.21%.
| Gross Margin | 71.16% |
| Operating Margin | 12.82% |
| Pretax Margin | 11.08% |
| Profit Margin | 8.21% |
| EBITDA Margin | 21.25% |
| EBIT Margin | 12.82% |
| FCF Margin | 11.38% |
Dividends & Yields
GSK pays an annual dividend of $1.96, which amounts to a dividend yield of 4.23%.
| Dividend Per Share | $1.96 |
| Dividend Yield | 4.23% |
| Dividend Growth (YoY) | -1.33% |
| Payout Ratio | 121.59% |
| Earnings Yield | 1.64% |
| FCF Yield | 4.56% |
Analyst Forecast
The average price target for GSK is $47, which is 22% higher than the current price. The consensus rating is "Hold".
| Price Target | $47 |
| Price Target Difference | 22% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jul 22, 2022. It was a backward split with a ratio of 4:5.
| Last Split Date | Jul 22, 2022 |
| Split Type | backward |
| Split Ratio | 4:5 |
Scores
| Altman Z-Score | 1.93 |
| Piotroski F-Score | 6 |